-
1
-
-
1942419326
-
Drug hepatotoxicity
-
Black M Drug hepatotoxicity. Clin Liver Dis 2003, 7:295-519.
-
(2003)
Clin Liver Dis
, vol.7
, pp. 295-519
-
-
Black, M.1
-
2
-
-
0036247148
-
Hepatotoxicity of antimicrobial agents
-
Brown SJ, Desmond PV Hepatotoxicity of antimicrobial agents. Semin Liver Dis 2002, 22:157-167.
-
(2002)
Semin Liver Dis
, vol.22
, pp. 157-167
-
-
Brown, S.J.1
Desmond, P.V.2
-
3
-
-
0036251569
-
Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs
-
Chitturi S, George J Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis 2002, 22:169-183.
-
(2002)
Semin Liver Dis
, vol.22
, pp. 169-183
-
-
Chitturi, S.1
George, J.2
-
4
-
-
0036868145
-
Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction
-
Chung C, Buchman AL Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction. Clin Liver Dis 2002, 6:1067-1084.
-
(2002)
Clin Liver Dis
, vol.6
, pp. 1067-1084
-
-
Chung, C.1
Buchman, A.L.2
-
5
-
-
0034067784
-
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
-
Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000, 118:705-713.
-
(2000)
Gastroenterology
, vol.118
, pp. 705-713
-
-
Dubinsky, M.C.1
Lamothe, S.2
Yang, H.Y.3
-
6
-
-
0036247430
-
Drugs and steatohepatitis
-
Farrell GC Drugs and steatohepatitis. Semin Liver Dis 2002, 22:185-194.
-
(2002)
Semin Liver Dis
, vol.22
, pp. 185-194
-
-
Farrell, G.C.1
-
7
-
-
0032701360
-
Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. The Acute Liver Failure Study Group
-
Fontana RJ, McCashland TM, Benner KG, et al. Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. The Acute Liver Failure Study Group. Liver Transpl Surg 1999, 5:480-484.
-
(1999)
Liver Transpl Surg
, vol.5
, pp. 480-484
-
-
Fontana, R.J.1
McCashland, T.M.2
Benner, K.G.3
-
8
-
-
0035986526
-
Drug hepatotoxicity
-
Goodman ZD Drug hepatotoxicity. Clin Liver Dis 2002, 6:381-397.
-
(2002)
Clin Liver Dis
, vol.6
, pp. 381-397
-
-
Goodman, Z.D.1
-
9
-
-
0028215036
-
Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity
-
Kremer JM, Alarcon GS, Lightfoot RW, et al. Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994, 37:316-326.
-
(1994)
Arthritis Rheum
, vol.37
, pp. 316-326
-
-
Kremer, J.M.1
Alarcon, G.S.2
Lightfoot, R.W.3
-
10
-
-
0036251054
-
Epidemiology and individual susceptibility to adverse drug reactions affecting the liver
-
Larrey D Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002, 22:145-155.
-
(2002)
Semin Liver Dis
, vol.22
, pp. 145-155
-
-
Larrey, D.1
-
11
-
-
0033790481
-
Liver damage associated with minocycline use in acne: a systematic review of the published review and pharmacovigilance data
-
Lawrenson RA, Seaman HE, Sundstrom A, et al. Liver damage associated with minocycline use in acne: a systematic review of the published review and pharmacovigilance data. Drug Saf 2000, 4:333-349.
-
(2000)
Drug Saf
, vol.4
, pp. 333-349
-
-
Lawrenson, R.A.1
Seaman, H.E.2
Sundstrom, A.3
-
12
-
-
0041342015
-
Drug-induced hepatotoxicity
-
Lee WM Drug-induced hepatotoxicity. N Engl J Med 2003, 349:474-485.
-
(2003)
N Engl J Med
, vol.349
, pp. 474-485
-
-
Lee, W.M.1
-
13
-
-
0036250397
-
Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States
-
Patel PA, Voigt MD Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States. Am J Gastroenterol 2002, 5:1198-1203.
-
(2002)
Am J Gastroenterol
, vol.5
, pp. 1198-1203
-
-
Patel, P.A.1
Voigt, M.D.2
-
14
-
-
0036226892
-
Acetaminophen hepatotoxicity: the first 35 years
-
Rumack BH Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol 2002, 40:3-20.
-
(2002)
J Toxicol Clin Toxicol
, vol.40
, pp. 3-20
-
-
Rumack, B.H.1
-
15
-
-
0034930107
-
Thiazolidinediones and liver toxicity
-
Scheen AJ Thiazolidinediones and liver toxicity. Diabetes Metab 2001, 27:305-313.
-
(2001)
Diabetes Metab
, vol.27
, pp. 305-313
-
-
Scheen, A.J.1
-
16
-
-
0034865733
-
Complementary and alternative medicine in chronic liver disease
-
Seefe LB, Lindsay KL, Bacon BR, et al. Complementary and alternative medicine in chronic liver disease. Hepatology 2001, 34:595-610.
-
(2001)
Hepatology
, vol.34
, pp. 595-610
-
-
Seefe, L.B.1
Lindsay, K.L.2
Bacon, B.R.3
-
17
-
-
0032955557
-
Hepatotoxicity of psychotropic drugs
-
Selim K, Kaplowitz N Hepatotoxicity of psychotropic drugs. Hepatology 1999, 29:1347-1351.
-
(1999)
Hepatology
, vol.29
, pp. 1347-1351
-
-
Selim, K.1
Kaplowitz, N.2
-
18
-
-
0034888045
-
Acute life-threatening toxicity of cancer treatment
-
Shanholtz C Acute life-threatening toxicity of cancer treatment. Crit Care Clin 2001, 17:483-502.
-
(2001)
Crit Care Clin
, vol.17
, pp. 483-502
-
-
Shanholtz, C.1
-
19
-
-
0036796798
-
Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during anti-tuberculosis treatment
-
Sharma SK, Balamurugan A, Saha PK, et al. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during anti-tuberculosis treatment. Am J Respir Crit Care Med 2002, 166:916-919.
-
(2002)
Am J Respir Crit Care Med
, vol.166
, pp. 916-919
-
-
Sharma, S.K.1
Balamurugan, A.2
Saha, P.K.3
-
20
-
-
0036257022
-
Herbal hepatotoxicity
-
Stedman C Herbal hepatotoxicity. Semin Liver Dis 2002, 22:195-222.
-
(2002)
Semin Liver Dis
, vol.22
, pp. 195-222
-
-
Stedman, C.1
-
21
-
-
0034606721
-
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
-
Sulkowski MS, Thomas DL, Chaisson RE, Moore RD Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000, 283:74-80.
-
(2000)
JAMA
, vol.283
, pp. 74-80
-
-
Sulkowski, M.S.1
Thomas, D.L.2
Chaisson, R.E.3
Moore, R.D.4
-
22
-
-
0036642493
-
Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy
-
Wit FW, Weverling GJ, Weel J, et al. Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy. J Infect Dis 2002, 186:23-31.
-
(2002)
J Infect Dis
, vol.186
, pp. 23-31
-
-
Wit, F.W.1
Weverling, G.J.2
Weel, J.3
-
23
-
-
0029083319
-
Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure
-
Zimmerman HJ, Maddrey WC Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995, 22:767-773.
-
(1995)
Hepatology
, vol.22
, pp. 767-773
-
-
Zimmerman, H.J.1
Maddrey, W.C.2
-
24
-
-
0034424966
-
Drug-induced liver disease
-
Zimmerman HJ Drug-induced liver disease. Clin Liver Dis 2000, 4:73-96.
-
(2000)
Clin Liver Dis
, vol.4
, pp. 73-96
-
-
Zimmerman, H.J.1
|